Detalles de la búsqueda
1.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol
; 98(12): 1856-1868, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772428
2.
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
J Hematol Oncol
; 15(1): 116, 2022 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36028857
3.
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Leukemia
; 35(12): 3444-3454, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34725454
4.
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Clin Lymphoma Myeloma Leuk
; 21(12): e985-e999, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511320
5.
Gene expression workflow to analyze residual leukemic cells in Chronic Lymphocytic Leukemia.
Int J Lab Hematol
; 42(4): 423-430, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333638
6.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Leukemia
; 34(9): 2354-2363, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32647324
7.
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy.
Clin Lymphoma Myeloma Leuk
; 18(11): 737-742, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30017595
Resultados
1 -
7
de 7
1
Próxima >
>>